Herman H. Yue

New York
  • 1271 Avenue of the Americas
  • New York, NY 10020
  • USA

Herman Yue, PhD, is intellectual property litigation partner in the New York office of Latham & Watkins. 

Dr. Yue's practice focuses on patent litigation, with primary emphasis on the life sciences and pharmaceutical industries. He has experience in all phases of complex patent litigation, from pre-suit investigation through trial and appeal. His prior matters include traditional patent infringement actions as well as litigation under the Biologics Price Competition and Innovation Act (BPCIA) and Hatch-Waxman Act. Dr. Yue has also litigated patent cases involving computer hardware and software, medical devices, and fracking technology.

In addition to his patent litigation practice, Dr. Yue routinely provides strategic patent counseling to clients. He has also appeared in inter partes review proceedings before the USPTO as well as administrative actions in the Japanese and European Patent Offices. His active pro bono practice includes immigration asylum cases and habeas corpus petitions.

Dr. Yue previously served as a law clerk to the late Judge Robert W. Sweet, Southern District of New York. While in law school, he served as managing editor of the NYU Journal of Legislation and Public Policy. He has been recognized as a New York Metro (2014) and Texas Rising Star by Super Lawyers (2017-2018). Super Lawyers is a Thomson Reuters service.

Dr. Yue received his PhD in Immunology from the University of California, Berkeley, Molecular and Cell Biology program where he was a National Science Foundation Predoctoral Research Fellow and was awarded an Outstanding Graduate Student Instructor Award. His graduate work focused on the study of the mammalian TRAIL receptor, a member of the TNF receptor superfamily, and he published the first knockout of the murine TRAIL receptor. He holds a US patent based on his graduate research.

Dr. Yue's representative experience includes:

  • Counsel for AbbVie in multiple lawsuits under the BPCIA involving Humira®, the first humanized monoclonal antibody drug
  • Counsel for developer and distributor of branded pharmaceutical, in an intellectual property lawsuit against a multinational generic pharmaceutical company
  • Icahn School of Medicine v. Neurocrine Biosciences: Represented Neurocrine in contract dispute involving patents covering recombinant DNA constructs
  • Enzo Life Sciences v. Life Technologies: Represented Life Technologies in patent litigation relating to DNA sequencing technology
  • Enerpol v. Schlumberger Technology Corp.: Counsel for Schlumberger in patent litigation involving polymer-based fracking technology    
  • RLIS v. Cerner Corp.: Trial counsel for Cerner in patent litigation over medical records software; patents found invalid and not infringed*
  • Tyco Healthcare Group v. Mutual: Obtained summary judgment on antitrust claims arising out of ANDA litigation*
  • Trial counsel for major pharmaceutical company in ANDA litigation over its blockbuster HIV protease inhibitor drug; patents found valid and infringed*
  • Represented major medical device manufacturer in patent litigation relating to its blockbuster drug-eluting cardiac stents*

*Matter handled prior to joining Latham

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.